Home โ€บ Cell Biology โ€บ How much antibody should I use in Chromatin Immunoprecipitation (ChIP) assays? | CST Tech Tips
Steps
  1. 1 Understand antibody optimization principles 00:20
  2. 2 Use recommended antibody concentration range 00:39
  3. 3 Scale antibody to chromatin DNA amount 01:06
  4. 4 Adjust antibody for larger IP volumes 01:30
  5. 5 Match control antibody concentration 01:52
Cell Biology Cell Signaling Technology

How much antibody should I use in Chromatin Immunoprecipitation (ChIP) assays? | CST Tech Tips

Protocol
Difficulty
intermediate

Steps

1
Understand antibody optimization principles

Learn that the optimal antibody amount for ChIP assays depends on the antibody's affinity, sensitivity, and specificity. Recognize that using more antibody does not always improve results, as both excess and insufficient antibody decrease ChIP signal.

โ–ถ 00:20
2
Use recommended antibody concentration range

Apply the standard recommendation of 0.5-2 ยตg of antibody per ChIP assay to generate an optimal signal-to-noise ratio. This range is based on in-house titration experiments performed by CST scientists using 10 ยตg of chromatin.

โ–ถ 00:39
3
Scale antibody to chromatin DNA amount

Maintain the ratio of antibody volume to chromatin DNA amount rather than to total IP volume. If using less than the recommended 10 ยตg of chromatin DNA per IP, decrease the antibody amount proportionally.

โ–ถ 01:06
4
Adjust antibody for larger IP volumes

Use the recommended 500 ยตL total volume per IP. If performing ChIP with the same chromatin DNA amount but in a larger volume, no additional antibody is required, although longer incubation time may help compensate for dilution.

โ–ถ 01:30
5
Match control antibody concentration

Use an equivalent amount of control antibody such as IgG as your test antibody to ensure a fair comparison between samples.

โ–ถ 01:52

๐Ÿšจ Failure Case Library (1) + Submit your own case

severe
High Background Signal in Non-Specific Antibody Controls
ChIP experiments show elevated signal levels in non-specific antibody controls (IgG or no-antibody controls), making it difficult to distinguish true binding events from background noise. The signal-to-noise ratio is poor, compromising data interpretation.
๐Ÿ’ก 5 ยท โœ“ 6
๐Ÿ’ฌ Comments coming soon